Association of cholecystectomy with osteoporosis risk: a prospective study using data from the UK Biobank

Front Endocrinol (Lausanne). 2023 Oct 20:14:1259475. doi: 10.3389/fendo.2023.1259475. eCollection 2023.

Abstract

Objective: To investigate whether prior cholecystectomy is associated with incident osteoporosis.

Background: Cholecystectomy may have consequences involving abnormal metabolism. Studies investigating the association between prior cholecystectomy and osteoporosis have yielded inconsistent results.

Methods: In total, 17,603 UK Biobank participants underwent cholecystectomy, and 35,206 matched controls were included in this study. They were followed up for incident osteoporosis, which was determined using ICD-10 codes (M80-82). The association between cholecystectomy and osteoporosis was assessed using Cox proportional regression modeling. The association between osteoporosis risk and cholecystectomy was further analyzed across age, sex, serum vitamin D level, and body mass index (BMI) categories.

Results: Within a median follow-up period of 13.56 years, 3,217 participants were diagnosed with osteoporosis. After adjustment for relevant confounders, prior cholecystectomy was associated with a 1.21 times higher risk of osteoporosis in women (hazard ratio (HR): 1.21 [95% CI, 1.12-1.31], p < 0.001) and a 1.45 times higher risk in men (HR: 1.45 [95% CI, 1.10-1.90], p = 0.007). In women, the association was stronger for patients who were aged 40-55 years, with BMI < 18.5 kg/m2, and vitamin D between 30 and 50 nmol/ml. No significant interactions between cholecystectomy and income level, education level, presence of hypertension, or diabetes were identified in either sex.

Conclusions: Our findings indicated that people who underwent cholecystectomy had a higher risk of developing osteoporosis after adjustment for potential confounders. Our findings suggest that awareness of the risk of osteoporosis in patients with a history of cholecystectomy is merited.

Keywords: cholecystectomy; cohort; gender difference; interaction; osteoporosis; risk factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Specimen Banks*
  • Cholecystectomy / adverse effects
  • Female
  • Humans
  • Male
  • Osteoporosis* / epidemiology
  • Osteoporosis* / etiology
  • Prospective Studies
  • United Kingdom / epidemiology
  • Vitamin D

Substances

  • Vitamin D

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Sichuan Science and Technology Program (23NSFSC5548, 22ZDYF1731, and 2021YFS0101), Chengdu Medical Association Research (2021145), and Chengdu High-level Key Clinical Specialty Construction Project.